FR2661833A1 - Method for preparing a water-soluble extract of fenugreek seeds and product obtained - Google Patents
Method for preparing a water-soluble extract of fenugreek seeds and product obtained Download PDFInfo
- Publication number
- FR2661833A1 FR2661833A1 FR9006213A FR9006213A FR2661833A1 FR 2661833 A1 FR2661833 A1 FR 2661833A1 FR 9006213 A FR9006213 A FR 9006213A FR 9006213 A FR9006213 A FR 9006213A FR 2661833 A1 FR2661833 A1 FR 2661833A1
- Authority
- FR
- France
- Prior art keywords
- water
- filtered
- seeds
- fenugreek
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000001484 Trigonella foenum graecum Nutrition 0.000 title claims abstract description 11
- 244000250129 Trigonella foenum graecum Species 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title claims abstract description 11
- 235000001019 trigonella foenum-graecum Nutrition 0.000 title claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 238000003756 stirring Methods 0.000 claims abstract description 7
- 238000011026 diafiltration Methods 0.000 claims abstract description 6
- 238000005119 centrifugation Methods 0.000 claims abstract description 5
- 239000012528 membrane Substances 0.000 claims abstract description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 5
- 230000008961 swelling Effects 0.000 claims abstract description 5
- 210000004207 dermis Anatomy 0.000 claims abstract description 4
- 230000014759 maintenance of location Effects 0.000 claims abstract description 4
- 206010052428 Wound Diseases 0.000 claims abstract description 3
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 3
- 230000032683 aging Effects 0.000 claims abstract description 3
- 230000002500 effect on skin Effects 0.000 claims abstract description 3
- 239000002537 cosmetic Substances 0.000 claims description 5
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 3
- 238000010348 incorporation Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000035876 healing Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- 241001605679 Colotis Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000001313 trigonella foenum graecum l. seed extract Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
PROCEDE DE PREPARATION D'EXTRAIT HYDROSOLUBLE DE GRAINES
DE FENUGREC ET PRODUIT OBTENU
La présente invention a pour objet un procédé de préparation d'extrait de graines de fenugrec et le produit obtenu.PROCESS FOR THE PREPARATION OF WATER-SOLUBLE SEED EXTRACT
OF FENUGREC AND PRODUCT OBTAINED
The subject of the present invention is a process for preparing fenugreek seed extract and the product obtained.
Le produit selon 1' invention est destiné à être incorporé à des compositions cosmétologiques et éventuellement pharmaceutiques, notamment dans des préparations ralentissant le vieillissement dermique, ou nourrisant le derme, par exemple destinées à être utilisées après exposition au soleil, ou encore dans des spécialités utilisées pour le traitement des plaies et brûlures.The product according to the invention is intended to be incorporated into cosmetic and possibly pharmaceutical compositions, in particular in preparations slowing down dermal aging, or nourishing the dermis, for example intended for use after exposure to the sun, or else in specialties used for the treatment of wounds and burns.
De nombreuses préparations d'origine végétales à base de fenugrec sont décrites dans la littérature depuis la plus haute antiquité.Many preparations of plant origin based on fenugreek have been described in the literature since ancient times.
Par exemple, dans le dernier livre du papyrus de SMITH, 3000 ans avant Jésus Christ, on cite 1'Hemalt. Cette interprétation correspond aux applications de la trigonelle décrites par PLINE, puis par les Arabes. Le papyrus d'Ebers, 2000 ans avant Jésus
Christ le mentionne dans le traitement des brûlures. Toutefois les préparations connues présentent un pouvoir trophique très limité et sont le plus souvent dépourvues de propriétés régénératrices et cicatrisantes.For example, in the last book of the SMITH papyrus, 3000 years before Jesus Christ, we quote the Hemalt. This interpretation corresponds to the applications of the trigonelle described by PLINE, then by the Arabs. The Ebers papyrus, 2000 years before Jesus
Christ mentions it in the treatment of burns. However, the known preparations have a very limited trophic power and are most often devoid of regenerative and healing properties.
L' extrait hydrosoluble de graines de fenugrec obtenu grâce au procédé objet de la présente invention présente au contraire de remarquables propriétés trophiques, régénératrices et cicatrisantes, ainsi qu'une très bonne tolérance par le derme. The water-soluble extract of fenugreek seeds obtained by the process which is the subject of the present invention, on the contrary, exhibits remarkable trophic, regenerative and healing properties, as well as very good tolerance by the dermis.
Le procédé suivant 1' invention consiste à provoquer le gonflement de fenugrec, de préférence originaire de 1' Inde, en versant dessus de l'eau filtrée à 450C à raison de 100 ml pour 100 gr de graines, puis à ajouter 15 minutes plus tard une quantité double d ' eau et à laisser infuser en agitant lentement pendant 45 minutes, la solution résultante étant ensuite filtrée puis les graines éliminées par essorage ou centrifugation, après quoi la solution est soumise à une diafiltration sur membrane poreuse calibrée présentant un seuil de rétention de substances dont le poids moléculaires est égal ou supérieur à 300 000. The process according to the invention consists in causing the swelling of fenugreek, preferably originating in India, by pouring filtered water at 450C at the rate of 100 ml per 100 gr of seeds, then adding 15 minutes later double the amount of water and leave to infuse while stirring slowly for 45 minutes, the resulting solution then being filtered and the seeds removed by spin or centrifugation, after which the solution is subjected to a diafiltration on a calibrated porous membrane having a retention threshold of substances with a molecular weight of 300,000 or more.
D' autres caractéristiques ressortent de la description détaillée suivante, qui concerne un exemple non limitatif d'une des formes de réalisation. Other characteristics will emerge from the following detailed description, which relates to a nonlimiting example of one of the embodiments.
Le produit selon la présente invention est obtenu en appliquant le procédé ci-après
On commence par obtenir le gonflement maximum de fenugrec en versant 100 ml d'eau à 45"C préalablement filtrée à 0,22 micron pour 100 gr de graines. Au bout de 15 minutes, on ajoute 200 ml d'eau filtrée à 0,22 micron à la même température et on laisse infuser en agitant lentement pendant 45 minutes.The product according to the present invention is obtained by applying the process below
We start by obtaining the maximum swelling of fenugreek by pouring 100 ml of water at 45 "C previously filtered at 0.22 micron per 100 gr of seeds. After 15 minutes, 200 ml of water filtered at 0 is added, 22 micron at the same temperature and allowed to infuse while stirring slowly for 45 minutes.
On obtient environ 140 ml de solution. Celle-ci est filtrée, puis les graines gonflées et humides sont éliminées par essorage ou centrifugation. L 'extrait obtenu est tout d ' abord jaune vif et brunit légèrement après quelques heures.About 140 ml of solution are obtained. This is filtered, then the swollen and moist seeds are removed by spin or centrifugation. The extract obtained is first of all bright yellow and browns slightly after a few hours.
On maintient ensuite la solution sous agitation à 37-40"C, puis on 1' introduit dans un appareil à diafiltrer équipé de membranes poreuses dont le seuil de rétention est à 300 000 et le diamètre apparent des pores approximativement de 2 angstroem. On fait circuler la totalité de la solution.The solution is then kept under stirring at 37-40 "C, then it is introduced into a diafiltration device equipped with porous membranes, the retention threshold of which is 300,000 and the apparent diameter of the pores approximately 2 angstroms. circulate the entire solution.
La solution diafiltrée est récupérée puis on y introduit 0,25 gr de chloramide T pour 100 gr. L ' extraction active isolée après diafiltration est jaune limpide.The diafiltered solution is recovered and then 0.25 g of chloramide T is introduced into it per 100 gr. The active extraction isolated after diafiltration is clear yellow.
Les caractéristiques physico-chimiques de 1' extrait sont les suivantes
Ph : 6, Densité : 1,002; Extrait sec : 0,5 %; Indice de réfraction : 1,334. The physicochemical characteristics of the extract are as follows
Ph: 6, Density: 1.002; Dry extract: 0.5%; Refractive index: 1.334.
Les quantités, durées de traitement et poids moléculaire indiqués ci-dessus sont donnés à titre indicatif et peuvent varier dans des proportions importantes.The quantities, duration of treatment and molecular weight indicated above are given as an indication and can vary within significant proportions.
Le principe actif peut être incorporé à des excipients habituellement utilisés dans les compositions cosmétologiques et pharmaceutiques, les véhicules aqueux ou non, les corps gras d ' origine animale ou végétale, les dérivés paraffiniques, les glycols, les divers agents mouillants, dispersants ou émulsifiants, les conservateurs. The active principle can be incorporated into excipients usually used in cosmetic and pharmaceutical compositions, aqueous vehicles or not, fatty substances of animal or vegetable origin, paraffinic derivatives, glycols, the various wetting agents, dispersants or emulsifiers, conservatives.
Grâce à sa remarquable efficacité, le produit qui vient d ' être décrit se prête particulièrement bien à la confection de spécialités cosmétologiques ou pharmacologiques en étant utilisé dans une proportion de 10 à 30 % dans les solutions crèmes, pommades, lotions, gouttes ou autres.Thanks to its remarkable effectiveness, the product which has just been described lends itself particularly well to the preparation of cosmetic or pharmacological specialties by being used in a proportion of 10 to 30% in creams, ointments, lotions, drops or other solutions.
Le positionnement des divers éléments constitutifs donnent à ce produit un maximum d ' effets utiles qui n ' avaient pas été obtenus à ce jour par des produits similaires. The positioning of the various constituent elements gives this product a maximum of useful effects which had not been obtained to date by similar products.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9006213A FR2661833B3 (en) | 1990-05-14 | 1990-05-14 | PROCESS FOR THE PREPARATION OF WATER-SOLUBLE EXTRACT OF FENUGREC SEEDS AND PRODUCT OBTAINED. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9006213A FR2661833B3 (en) | 1990-05-14 | 1990-05-14 | PROCESS FOR THE PREPARATION OF WATER-SOLUBLE EXTRACT OF FENUGREC SEEDS AND PRODUCT OBTAINED. |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2661833A1 true FR2661833A1 (en) | 1991-11-15 |
FR2661833B3 FR2661833B3 (en) | 1992-07-10 |
Family
ID=9396734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9006213A Expired - Lifetime FR2661833B3 (en) | 1990-05-14 | 1990-05-14 | PROCESS FOR THE PREPARATION OF WATER-SOLUBLE EXTRACT OF FENUGREC SEEDS AND PRODUCT OBTAINED. |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2661833B3 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995021199A1 (en) * | 1994-02-07 | 1995-08-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Galactomannan products and compositions containing the same |
EP0742007A1 (en) * | 1995-05-12 | 1996-11-13 | Laboratoires Serobiologiques | Use of cassia and/or fenugreek seed extracts enriched in galactomannans and cosmetics or pharmaceuticals containing them |
-
1990
- 1990-05-14 FR FR9006213A patent/FR2661833B3/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995021199A1 (en) * | 1994-02-07 | 1995-08-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Galactomannan products and compositions containing the same |
EP0742007A1 (en) * | 1995-05-12 | 1996-11-13 | Laboratoires Serobiologiques | Use of cassia and/or fenugreek seed extracts enriched in galactomannans and cosmetics or pharmaceuticals containing them |
FR2733908A1 (en) * | 1995-05-12 | 1996-11-15 | Serobiologiques Lab Sa | USE OF EXTRACTS OF CASSIA SEEDS AND / OR TRIGONELLA ENRICHED IN GALACTOMANNANS AND COSMETIC OR PHARMACEUTICAL PRODUCT, ESPECIALLY DERMATOLOGICAL, CONTAINING SUCH EXTRACTS |
Also Published As
Publication number | Publication date |
---|---|
FR2661833B3 (en) | 1992-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE891088R (en) | COMPOSITION BASED ON BENZOYL PEROXIDE | |
EP0755674B1 (en) | Stable composition containing ascorbic acid | |
EP0296923B1 (en) | Liposomal composition containing a mulberrytree extract | |
EP0077742B1 (en) | Copper lanolate and topic compositions containing it | |
EP0425398B1 (en) | Aloe solution, preparation process and compositions containing it | |
FR2730408A1 (en) | COMPOSITIONS WITH DEPIGMENTING ACTIVITY AND APPLICATIONS THEREOF | |
LU84485A1 (en) | NOVEL ANTI-ACNE COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE OTHER ACTIVE INGREDIENT | |
LU87408A1 (en) | USE OF SALICYL DERIVATIVES FOR THE TREATMENT OF AGING SKIN | |
EP0926956B1 (en) | Use of algae extract as antibacterial and/or antifungal agent and composition containing same | |
FR2653334A1 (en) | COSMETIC TANNING PREPARATION. | |
FR2502005A1 (en) | SKIN REGENERATING COSMETIC COMPOSITION AND PROCESS FOR PREPARING THE SAME | |
EP0595988B1 (en) | Cosmetic compositions comprising an extract of eclipta alba | |
FR2490492A1 (en) | Compsns. for treating cellulitis - contg. xanthine base and seaweed extract | |
FR2657012A1 (en) | Use of extracts of microscopic algae for the preparation of pharmaceutical, cosmetic or nutrient compositions or compositions for agricultural use | |
EP2167016B1 (en) | Chitosan carboxyalkylamide hydrogel, preparation thereof and cosmetic and dermatological use thereof | |
FR2748659A1 (en) | TOPICAL SLIMMING COMPOSITION | |
FR2661833A1 (en) | Method for preparing a water-soluble extract of fenugreek seeds and product obtained | |
FR3013985A1 (en) | MOISTURIZING COMPOSITIONS COMPRISING AT LEAST ONE CAESALPINIA SPINOSA EXTRACT WITH AT LEAST VASELIN AND GLYCERIN | |
FR2660196A1 (en) | Method for the manufacture of water-soluble cell extract of egg embryos and product obtained | |
FR2543828A1 (en) | NOVEL ANTI-ACNEIC COMPOSITION BASED ON TIOXOLONE AND AT LEAST ONE OTHER ACTIVE INGREDIENT | |
WO1994015626A9 (en) | Cosmetic or pharmaceutical and particularly dermatological composition containing a vismia extract | |
CA1074229A (en) | Process for the extraction of calf embryo skins, proteinic substances so obtained and cosmetic and pharmaceutical compositions containing same | |
EP0679087A1 (en) | Cosmetic or pharmaceutical and particularly dermatological composition containing a vismia extract. | |
CH664895A5 (en) | STABLE ANTHRALIN COMPOSITION IN SATURATED FATTY ACID TRIGLYCERIDES OF PLANT ORIGIN HAVING 6 TO 12 CARBON ATOMS. | |
FR2780277A1 (en) | Use of lipid extracts from mirabelle tree seeds in cosmetics for skin, hair etc |